-
Mashup Score: 5ASGCT 2025: Gates Foundation "Doubling Down" on HIV Cure - 2 hour(s) ago
Mike McCune said the Gates Foundation is “doubling down” on finding a cure for HIV during an ASGCT symposium.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 4The News from New Orleans: GEN's Takeaways from ASGCT - 6 hour(s) ago
Kevin Davies and Julianna LeMieux chat about news from the ASGCT meeting live from the conference floor.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet-
The News from New Orleans: GEN's Takeaways from ASGCT Kevin Davies and Julianna LeMieux chat about what they have been blown away by live from the ASGCT meeting conference floor. @kiranmusunuru @MackenzieTippi @ASGCTherapy @julemieux1 @KevinADavies https://t.co/4sDzPF8WtC
-
-
Mashup Score: 3Ready to Drive Cell Therapy Success? Here Are the Keys. - 7 hour(s) ago
Careful planning can make a substantial difference on your path to commercial success. Here we delve into key considerations for helping you navigate cell therapy PD smoothly and efficiently.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet-
Ready to Drive Cell Therapy Success? Here Are the Keys. Careful planning can make a difference on your path to commercial success. We delve into key considerations for helping you navigate cell therapy PD smoothly and efficiently. Sponsored by @Cytiva https://t.co/59DGKZVQe0
-
-
Mashup Score: 10
In this GEN webinar, three informatics experts discuss how modern informatics platforms and AI technologies can restructure drug research and development workflows in academic labs and pharmaceutical organizations to expedite drug discovery.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet-
NEW WEBINAR! On 6/12, three informatics experts discuss how modern informatics platforms and AI technologies can restructure drug research and development workflows in academic labs to expedite drug discovery. REGISTER: https://t.co/y8h9K1Z2IT @CDDVault https://t.co/nEfOFyYiuC
-
-
Mashup Score: 63PBIOVIAN Introduces Two Platforms for AAV and pDNA Manufacturing - 19 hour(s) ago
In addition to complementing AAV manufacturing, the company’s Plasmid DNA (pDNA) platform is now available as a standalone service.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet-
3PBIOVIAN Introduces Two Platforms for AAV and pDNA Manufacturing In addition to complementing AAV manufacturing, the company’s Plasmid DNA (pDNA) platform is now available as a standalone service. #3PBIOVIAN #DNA #bioprocessing #cell #gene https://t.co/QI8zFuCfNz
-
-
Mashup Score: 2
BioMarin agreed to shell out approximately $270 million for Inozyme Pharma, a developer whose treatments target the PPi-adenosine pathway, a key regulator of bone health and blood vessel function.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet-
Don't Miss Alex Philippidis Latest StockWatch! With @inozyme buyout, @BioMarin pursues growth via M&A. Pluse @bluebirdbio shares jumped; @Septerna_Inc shares leaped; and @UroGenPharma shares tumbled. #StockMarket @AlexWestchester https://t.co/kIvC1fsvp8
-
-
Mashup Score: 4Breaking the Bottleneck: On-Demand Biology in the Age of AI - 1 day(s) ago
© 2025 Mary Ann Liebert, Inc. Publishers. All rights reserved.
Source: promo.genengnews.comCategories: General Medicine News, Future of MedicineTweet-
New eBook! The worlds of synthetic biology and artificial intelligence are becoming increasingly interconnected, reshaping how scientific breakthroughs are achieved. DOWNLOAD this free eBook sponsored by Telesis Bio: https://t.co/AP6Xpk9GmR https://t.co/2pldErhbQ3
-
-
Mashup Score: 17EvoCAST Harnesses CRISPR-Linked Bacterial Transposes to Insert Genes Into Human Cells - 1 day(s) ago
This is the first gene editor to use a CRISPR-associated transposase to make targeted edits at therapeutically useful levels in humans.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet-
EvoCAST Harnesses CRISPR-Linked Bacterial Transposes to Insert Genes Into Human Cells This is the first gene editor to use a #CRISPR-associated transposase to make targeted edits at therapeutically useful levels in humans @broadinstitute @Columbia #gene https://t.co/XsvT1cKBxh
-
-
Mashup Score: 39
Controlling the entire cell therapy production process—from material receipt to product release—is essential.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet-
AstraZeneca’s New $300M Plant Provides Control of Cell Therapy Production Controlling the entire cell therapy production process—from material receipt to product release—is essential. @AstraZeneca #bioprocessing #biomanufacturing #CellImmunotherapy https://t.co/Gbew8c5dKj
-
-
Mashup Score: 14
Although not designed to eliminate experiments, the model, which is intended to accelerate process development, can reduce the number needed.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet-
Optimizing Culture Media Using Small Datasets via New Computer Model Although not designed to eliminate experiments, the model, which is intended to accelerate process development, can reduce the number needed. https://t.co/sKFYDlQU1D
-
ASGCT 2025: Gates Foundation "Doubling Down" on HIV Cure Mike McCune, MD, PhD, head of the HIV Frontiers Program at the @gatesfoundation, said the foundation is “doubling down” on finding a cure for HIV during an @ASGCTherapy symposium. #ASGCT2025 #HIV https://t.co/jOWOQsxamX